A.R.T. Advisors, LLC - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 105 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2019$79,000
-36.8%
16,427
-20.4%
0.00%
-33.3%
Q3 2019$125,000
-72.8%
20,627
-68.2%
0.01%
-78.6%
Q1 2019$460,000
+22.7%
64,911
+27.0%
0.03%
+64.7%
Q3 2018$375,000
-11.3%
51,113
-22.9%
0.02%0.0%
Q2 2018$423,000
-40.3%
66,313
-49.1%
0.02%
-39.3%
Q1 2018$708,000
+238.8%
130,214
+159.4%
0.03%
+211.1%
Q4 2017$209,000
-48.5%
50,190
+58.3%
0.01%
-52.6%
Q1 2017$406,000
-41.6%
31,700
-44.2%
0.02%
-53.7%
Q4 2016$695,000
+281.9%
56,800
+266.5%
0.04%
-30.5%
Q3 2016$182,000
-42.0%
15,500
-74.1%
0.06%
+321.4%
Q1 2016$314,000
-51.9%
59,748
-29.1%
0.01%
-54.8%
Q4 2015$653,000
+26.1%
84,248
+111.0%
0.03%
+72.2%
Q1 2015$518,000
+165.6%
39,923
+83.1%
0.02%
+100.0%
Q3 2014$195,000
-44.4%
21,799
-38.3%
0.01%
-52.6%
Q1 2014$351,000
-40.1%
35,350
-37.7%
0.02%0.0%
Q2 2013$586,00056,7050.02%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders